General method may be used for any type of disease if an adequate size sample of microarrays from previously classified disease is available

Development Milestones

Seeking industry cooperation for further development with companies that can prepare datasets

The Opportunity

25 million people in Japan, Europe and North America have cancer; 10.1 million additional cases diagnosed worldwide each year. By 2020, that number will grow to 15 million new cases annually. (World Health Organization)